Photosynthesis decreases in N stressed cells. by Steve Dagenais Bellefeuille (654383)

ATRA decreased TGF-β1 content in LT cultures in a concentration-dependent manner. by Carmen Retana (479628)

Reduced I_A decreases the stimulus threshold for short-term synaptic plasticity. by Ángela Fontán-Lozano (193161)

Pharmacological treatments decrease actin polymerization. by Romain Ferru-Clément (701878)

Many plasmalogens decrease upon infection. by Gaelle Boncompain (513910)

“…Putative plasmalogens were identified based on their predicted formula as C_xH_2x–2yNO₇P (where y = the number of double bonds in the fatty acid) after ICR-FT/MS analysis (mass error <100 parts/billion, MassTRIX <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0086196#pone.0086196-Suhre1" target="_blank">[46]</a>), and on their sensitivity to acid hydrolysis. …”

Decrease in loss during the training process. by Muhammad Idrees (92773)

A decreased expression of Rab4b increased GLUT4 localization at the plasma membrane. by Vincent Kaddai (264976)

Graphs showing periods of electrical activity of muscles at each grade across a normalized stride cycle (0%–100% hoof strike to subsequent hoof strike). by Yuji Takahashi (263525)

Resveratrol decreases PKM2 expression. by Mohd Askandar Iqbal (324124)

“…Western blot showing decreased PKM2 protein in all the cell lines studied on treatment with 50 µM resveratrol (D). …”

AKT inhibition decreases neuroblast populations. by Maria R. Aburto (186884)

“…The data are shown as the mean ± SEM and the statistical significance between the different conditions was estimated by Student's t-test: *P<0.05, ***P<0.001, versus control (0S). …”

Ellagic acid decreases lysosomal integrity. by Ahmad Salimi (10204515)

Ellagic acid decreases ROS formation. by Ahmad Salimi (10204515)

Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

Ellagic acid decreases mitochondrial damages. by Ahmad Salimi (10204515)

Quercetin decreased mitochondrial- and intercellular ROS. by Takaya Sugawara (9338487)

Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

“…At 12 weeks of treatment with pitavastatin compared to placebo; mean [95% confidence interval (CI)] total cholesterol (TC) was 207 (187.3, 226.8) mg/dL vs 246.3 (226.5, 266) mg/dL (<i>p</i> <0.001); mean (95% CI) triglyceride (TG) was 351.3 (193.2, 509.4) mg/dL vs 279.1 (121, 437.2) mg/dL (<i>p</i> = 0.269); mean (95% CI) high density lipoprotein (HDL) was 45.3 (40.4, 50.2) mg/dL vs 44.2 (39.3, 49.1) mg/dL (<i>p</i> = 0.354); and mean (95% CI) low density lipoprotein (LDL) was 113.2 (100.4, 126) mg/dL vs 145.6 (132.8, 158.4) mg/dL (<i>p</i> <0.001). …”

Simvastatin decreases eNOS expression. by Mohammed Sabri (355717)

Nanoparticle formulation decreases curcumin cytotoxicity. by Upendhar Gandapu (208623)

At lower concentrations, METH decreases LTP. by Jarod Swant (246454)

“…</b> * = <i>P</i><0.05, ** = <i>P</i><.01, *** = <i>P</i><.001; different from drug free. Error bars depict mean ± SEM.</p>…”

Neuroapoptosis decreases following CO exposure. by Ying Cheng (288456)